Duke Clinical Research Institute, Durham, North Carolina.
Division of Cardiology, Duke University Medical Center, Durham, North Carolina.
JAMA Cardiol. 2018 Mar 1;3(3):252-259. doi: 10.1001/jamacardio.2017.5250.
Hospitalizations for worsening heart failure (WHF) represent an enormous public health and financial burden, with physicians, health systems, and payers placing increasing emphasis on hospitalization prevention. In addition, maximizing time out of the hospital is an important patient-centered outcome. In this review, we discuss the concept of outpatient WHF, highlight the rationale and data for the outpatient treatment of WHF as an alternative to hospitalization, and examine opportunities and strategies for developing outpatient "interceptive" therapies for treatment of worsening symptoms and prevention of hospitalization.
Worsening heart failure has traditionally been synonymous with an episode of in-hospital care for worsening symptoms. While WHF often leads to hospitalization, many patients experience WHF in the outpatient setting and carry a similarly poor prognosis. These findings support WHF as a distinct condition, independent of location of care. For those that are hospitalized, most patients have an uncomplicated clinical course, with diuretics as the only intravenous therapy. Although complicated scenarios exist, it is conceivable that improved tools for outpatient management of clinical congestion would allow a greater proportion of hospitalized patients to receive comparable care outside the hospital. Most patients with WHF have a gradual onset of congestive signs and symptoms, offering a potential window in which effective therapy may abort continued worsening and obviate the need for hospitalization. To date, outpatient WHF has received minimal attention in randomized clinical trials, but this high-risk group possesses key features that favor effective clinical trial investigation.
As the public health and economic burdens of heart failure continue to grow, recognizing the entity of outpatient WHF is critical. Efforts to reduce heart failure hospitalization should include developing effective therapies and care strategies for outpatient WHF. The outpatient WHF population represents a major opportunity for therapeutic advancements that could fundamentally change heart failure care delivery.
因心力衰竭恶化(WHF)而住院治疗会给公共卫生和财政带来巨大负担,医生、医疗体系和支付方越来越重视预防住院。此外,最大限度地减少住院时间也是一个重要的以患者为中心的结果。在这篇综述中,我们讨论了门诊 WHF 的概念,强调了将 WHF 的门诊治疗作为住院替代方案的理由和数据,并探讨了为治疗恶化症状和预防住院而开发门诊“干预性”疗法的机会和策略。
传统上,WHF 一直等同于住院期间因症状恶化而住院的情况。虽然 WHF 通常会导致住院,但许多患者在门诊环境中经历 WHF,并具有类似的不良预后。这些发现支持 WHF 作为一种独立的疾病状态,独立于治疗地点。对于那些住院的患者,大多数患者的临床过程都很简单,仅使用利尿剂作为唯一的静脉治疗。尽管存在复杂的情况,但可以想象,如果有更好的工具用于门诊管理临床充血,就可以让更多的住院患者在医院外接受类似的治疗。大多数 WHF 患者都有充血性体征和症状逐渐出现的情况,这为有效治疗提供了一个潜在的窗口期,可以阻止病情进一步恶化,避免住院治疗。迄今为止,门诊 WHF 在随机临床试验中受到的关注很少,但这个高风险群体具有有利于有效临床试验研究的关键特征。
随着心力衰竭的公共卫生和经济负担继续增加,认识门诊 WHF 的实体至关重要。减少心力衰竭住院的努力应包括为门诊 WHF 开发有效的治疗方法和护理策略。门诊 WHF 人群为治疗进展提供了一个重要机会,这可能从根本上改变心力衰竭的护理提供方式。